BridgeMD
REQUIRED DOSE OF CHOLECALCIFEROL IN THE MANAGEMENT OF VITAMIN D DEFICIENCY AND INSUFFICIENCY IN POSTMENOPAUSAL WOMEN
EU CTIS ID: 2023-504664-42-02
What this study is testing
Efficacy of the use of Cholecalciferol in postmenopausal women with vitamin D deficiency or insufficiency
- Therapeutic confirmatory (Phase III)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Female patients aged ≥ 45 years.
- Menopausal women with more than one year of amenorrhea.
- Women with deficiency(40pt) of Vit D (25(OH) Vit D < 20 ng/ml), and with insufficiency(40pt) of Vit D (25(OH) Vit D, 20-30 ng/ml).
- Women who are willing to participate, and who are able to understand the explanation given to them about the nature of the study.
- Signed written informed consent.
You likely can't join if
- Patients with chronic decompensated diseases
- Mental condition that prevents them from consenting to participate in the study.
- Optimal vitamin D levels
- Allergy to one of the product's compounds.
- Concomitant use, or in the last 4 weeks, of other products containing vitamin D.
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 65+ years, 18-64 years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.